The 12th HTAsiaLink Annual Conference, held on 19–22 August 2025 in Singapore, attracted health technology assessment (HTA) experts from across the Asia-Pacific region. The event welcomed over 450 participants from 98 organizations and showcased 175 abstracts, alongside three plenary sessio

India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co

Finding true north is important for accurate navigation to embarking on the right path. While there may be many paths to making policy decisions, the ultimate goal is to end up with a decision that has been well-informed by evidence. Evidenced-based policy decisions result in more transparent and ef

The Prince Mahidol Award Conference (PMAC) 2020 took place in Bangkok between January 28th and February 2nd. This year PMAC was combined with the Universal Health Coverage (UHC) Forum, and the theme for the conference was Accelerating Progress towards UHC. Every year the conference attracts an array

SA IS in the process of preparing for a National Health Insurance (NHI) scheme to reach universal health coverage by 2025. Attaining this goal in a resource-constrained environment will rely in part on understanding which interventions should be prioritised and how resources should be allocated.Our

Historical development of health technology assessment in Thailand Teerawattananon Y*, Tantivess S*, Yothasamut J*, Kingkaew P *, Chaisiri K*. *Health Intervention and Technology Assessment Program, Thailand Objectives This study aims to review the development of health technology assessme

Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr

This study aims to assess the impact of the compulsory licensing (CL ) policy issued by Thailand’s Ministry of Public Health during December 2006 to January 2008 on antiretroviral drugs - efavirenz and lopinavir/ritonavir combination, an oral antiplatelet agent - clopidogrel, and four anti-cancer drugs - imatinib, erlotinib, letrozole, and doceta

A number of collaborative works between MoPH hospitals and the private sector were observed. Health services collaboration is the most obvious and popular model adopted by many MoPH hospitals. Until now, these has been no clear policy regarding such collaborations and this has led to drawbacks. Authors proposed a collaborative framework should be c

Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program. Tantivess S1 Teerawattananon Y1 Mills A1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand 2 London